- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Warner Chilcott PLC
Add to PortfolioWCRX:US
20.3300 USD 0.1300 0.64%As of 20:10:00 ET on 05/29/2012.
Snapshot for Warner Chilcott PLC (WCRX)
| Open: | 20.1000 | Day's Range: | 19.9900 - 20.4900 | Volume: | 3,084,135 | Bid: | 20.3100 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 20.2000 | 52wk Range: | 12.9000 - 24.6500 | 1-Yr Rtn: | -16.27% | Ask: | 20.3200 |
Key Statistics for WCRX
| Current P/E Ratio (ttm) | 12.8671 |
|---|---|
| Estimated P/E (12/2012) | 5.8336 |
| Earnings Per Share (USD) (ttm) | 1.5800 |
| Est. EPS (USD) (12/2012) | 3.4850 |
| Est. PEG Ratio | 0.7168 |
| Market Cap (M USD) | 5,091.07 |
| Shares Outstanding (M) | 250.42 |
| Enterprise Value (M USD) (ttm) | 8,157.07 |
| Enterprise Value/EBITDA (ttm) | 5.75 |
| Price/Book (mrq) | 30.1086 |
| Price/Sale (ttm) | 1.9207 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/06/2012 |
More WCRX Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for WCRX
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for WCRX
Warner Chilcott PLC is a pharmaceutical company. The Company is focused on marketing, selling, developing and manufacturing branded prescription pharmaceutical products in women's healthcare and dermatology in the United States.
| John Alexander KingChairman | Roger M BoissonneaultPresident/CEO |
| W Carl ReichelPres:Pharmaceuticals | Paul S HerendeenExec VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page